GlassScriptPhysician profile
Mary Ferraro
NPI 1356472195
$1,359.10
in general payments reported to CMS, 2019-2025
16 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $751 · 2022: $108 · 2023: $238 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $231.48 | 2021-2022 | |
| Axsome Therapeutics, INC. | $206.46 | 2023-2025 | Sunosi |
| Enterra Medical, INC. | $169.90 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.89 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $135.96 | 2021 | |
| Genzyme Corporation | $123.50 | 2023 | |
| Collegium Pharmaceutical, INC. | $79.80 | 2021-2022 | |
| Abbvie INC. | $67.60 | 2021-2022 | |
| Lundbeck LLC | $34.87 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $33.38 | 2021 | |
| Baudax Bio INC. | $32.59 | 2021 | |
| Scilex Pharmaceuticals INC. | $30.59 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $26.83 | 2021 | |
| Eisai INC. | $16.05 | 2022 | |
| Medtronic, INC. | $14.83 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ferraro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.